CommercialAdministrativeLow impact
07.00.20g, Routine Costs Associated with Qualifying Clinical Trials
Independence Blue Cross·Oncology, Cardiology, Neurology +5 more·Medical Policy
Effective date
Nov 26, 2025
We identified it
Jun 19, 2026
Summary
IBX Commercial has reissued policy 07.00.20g regarding routine costs associated with qualifying clinical trials, effective November 26, 2025. This is a policy reissuance with no apparent changes to existing coverage guidelines for clinical trial-related billing.
Action Required
By November 26, 2025: Billing team should review the updated policy document at the provided URL to confirm no changes to current clinical trial billing procedures. Verify that existing workflows for billing routine costs associated with qualifying clinical trials remain compliant with the reissued policy.